Matera MG - Search Results

1

A comparison of the bronchodilating effects of salmeterol, salbutamol and ipratropium bromide in patients with chronic obstructive pulmonary disease.

Matera MG, Cazzola M, Vinciguerra A, Di Perna F, Calderaro F, Caputi M, Rossi F. Matera MG, et al. Pulm Pharmacol. 1995 Dec;8(6):267-71. doi: 10.1006/pulp.1995.1036. Pulm Pharmacol. 1995. PMID: 8819181 Clinical Trial.

2

Salmeterol and formoterol in partially reversible severe chronic obstructive pulmonary disease: a dose-response study.

Cazzola M, Matera MG, Santangelo G, Vinciguerra A, Rossi F, D'Amato G. Cazzola M, et al. Among authors: matera mg. Respir Med. 1995 May;89(5):357-62. doi: 10.1016/0954-6111(95)90008-x. Respir Med. 1995. PMID: 7638371 Free article. Clinical Trial.

3

Effect of salmeterol and formoterol in patients with chronic obstructive pulmonary disease.

Cazzola M, Santangelo G, Piccolo A, Salzillo A, Matera MG, D'Amato G, Rossi F. Cazzola M, et al. Among authors: matera mg. Pulm Pharmacol. 1994 Apr;7(2):103-7. doi: 10.1006/pulp.1994.1012. Pulm Pharmacol. 1994. PMID: 7915921 Clinical Trial.

4

Effect of telenzepine, an M1-selective muscarinic receptor antagonist, in patients with nocturnal asthma.

Cazzola M, Matera MG, Liccardi G, Sacerdoti G, D'Amato G, Rossi F. Cazzola M, et al. Among authors: matera mg. Pulm Pharmacol. 1994 Apr;7(2):91-7. doi: 10.1006/pulp.1994.1010. Pulm Pharmacol. 1994. PMID: 8081076 Clinical Trial.

5

A combination with clinical recommended dosages of salmeterol and ipratropium is not more effective than salmeterol alone in patients with chronic obstructive pulmonary disease.

Matera MG, Caputi M, Cazzola M. Matera MG, et al. Respir Med. 1996 Sep;90(8):497-9. doi: 10.1016/s0954-6111(96)90178-x. Respir Med. 1996. PMID: 8869445 Free article. Clinical Trial. No abstract available.

6

The use of bronchodilators in stable chronic obstructive pulmonary disease.

Cazzola M, Spina D, Matera MG. Cazzola M, et al. Among authors: matera mg. Pulm Pharmacol Ther. 1997 Jun;10(3):129-44. doi: 10.1006/pupt.1997.0087. Pulm Pharmacol Ther. 1997. PMID: 9514624 Review. No abstract available.

7

A comparison of bronchodilating effects of salmeterol and oxitropium bromide in stable chronic obstructive pulmonary disease.

Cazzola M, Matera MG, Di Perna F, Calderaro F, Califano C, Vinciguerra A. Cazzola M, et al. Among authors: matera mg. Respir Med. 1998 Feb;92(2):354-7. doi: 10.1016/s0954-6111(98)90121-4. Respir Med. 1998. PMID: 9616538 Free article. Clinical Trial.

8

Effects of formoterol, salmeterol or oxitropium bromide on airway responses to salbutamol in COPD.

Cazzola M, Di Perna F, Noschese P, Vinciguerra A, Calderaro F, Girbino G, Matera MG. Cazzola M, et al. Among authors: matera mg. Eur Respir J. 1998 Jun;11(6):1337-41. doi: 10.1183/09031936.98.11061337. Eur Respir J. 1998. PMID: 9657576 Free article. Clinical Trial.

9

Cardiac effects of formoterol and salmeterol in patients suffering from COPD with preexisting cardiac arrhythmias and hypoxemia.

Cazzola M, Imperatore F, Salzillo A, Di Perna F, Calderaro F, Imperatore A, Matera MG. Cazzola M, et al. Among authors: matera mg. Chest. 1998 Aug;114(2):411-5. doi: 10.1378/chest.114.2.411. Chest. 1998. PMID: 9726723 Clinical Trial.

10

Early reversibility to salbutamol does not always predict bronchodilation after salmeterol in stable chronic obstructive pulmonary disease.

Cazzola M, Vinciguerra A, Di Perna F, Matera MG. Cazzola M, et al. Among authors: matera mg. Respir Med. 1998 Aug;92(8):1012-6. doi: 10.1016/s0954-6111(98)90347-x. Respir Med. 1998. PMID: 9893768 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

451 results

Search Page

Filters